Cargando…
Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles
New drugs targeting bile acid metabolism are currently being evaluated in clinical studies for their potential to treat cholestatic liver diseases, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Changes in bile acid metabolism, however, translate into an alterati...
Autores principales: | Zhang, Boyan, Kuipers, Folkert, de Boer, Jan Freark, Kuivenhoven, Jan Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745251/ https://www.ncbi.nlm.nih.gov/pubmed/35011746 http://dx.doi.org/10.3390/jcm11010004 |
Ejemplares similares
-
Impaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid Lipase
por: Sachdev, Vinay, et al.
Publicado: (2021) -
Glucose‐6‐Phosphate Regulates Hepatic Bile Acid Synthesis in Mice
por: Hoogerland, Joanne A., et al.
Publicado: (2019) -
Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition
por: Verkade, Esther, et al.
Publicado: (2023) -
Bile Acid Sequestration Reduces Plasma Glucose Levels in db/db Mice by Increasing Its Metabolic Clearance Rate
por: Meissner, Maxi, et al.
Publicado: (2011) -
Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70(−/−) Mice with a Human-like Bile Acid Composition
por: Palmiotti, Anna, et al.
Publicado: (2023)